Zhejiang Medicine Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Public, Subsidiary
- Established
- 1997-05-16
- Employees
- 6.2K
- Market Cap
- -
- Website
- http://www.lai-yi.com
Vitamin E Versus Placebo for the Treatment of Non Diabetic Patients With Nonalcoholic Steatohepatitis
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-11-11
- Last Posted Date
- 2023-04-03
- Lead Sponsor
- Zhejiang Medicine Co., Ltd.
- Target Recruit Count
- 120
- Registration Number
- NCT02962297
- Locations
- 🇨🇳
302 Military Hospital of China, Beijing, China
🇨🇳West China Hospital, Sichuan university, Chengdu, China
🇨🇳Guangdong Provincial Chinese Medicine Hospital, Guangzhou, China
Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Severe Impaired Renal Function
- First Posted Date
- 2016-07-21
- Last Posted Date
- 2018-04-03
- Lead Sponsor
- Zhejiang Medicine Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT02840812
- Locations
- 🇨🇳
ZheJiang Medicine, Shaoxing, China
Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Moderate Impaired Hepatic Function
- First Posted Date
- 2015-11-13
- Last Posted Date
- 2018-03-30
- Lead Sponsor
- Zhejiang Medicine Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT02604498
- Locations
- 🇨🇳
Huashan Hospital, Fudan University, Shanghai, Shanghai, China
A Dose-escalation Study of ARX788, IV Administered in Subjects With Advanced Cancers With HER2 Expression
- First Posted Date
- 2015-07-30
- Last Posted Date
- 2020-06-05
- Lead Sponsor
- Zhejiang Medicine Co., Ltd.
- Target Recruit Count
- 9
- Registration Number
- NCT02512237
- Locations
- 🇦🇺
Monash Medical Centre, Clayton, Victoria, Australia
🇳🇿Wellington Hospital, Newtown, Wellington, New Zealand
🇦🇺Mater Adult Hospital, South Brisbane, Queensland, Australia
© Copyright 2024. All Rights Reserved by MedPath